SPTLC1 p.Ser331=
c.993C>T · rs141150508 · VCV917299
Likely benign
Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 4 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0164%, mid)
Conditions
2
Charcot-Marie-Tooth disease
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -5.3 | GERP -3.7 |
| Overall | ||
| CADD | 0.889 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
gnomAD v4.1 · exomes + genomes
Grpmax group
0.0164%
Middle Eastern · 1/6,082 alleles
Filtering AF
0.00594%
ClinGen BA1/BS1 input
FAF95, joint · FAF99 0.00453%
Overall
0.00223%
36/1,613,834 alleles · ultra-rare
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Middle Easterngrpmax | 0.0164% | 6,082 |
| South Asian | 0.011% | 9,109 |
| East Asian | 0.00891% | 11,223 |
| Remaining individualsnot grpmax-eligible | 0.0048% | 20,826 |
| European (non-Finnish) | 0.00144% | 69,405 |
| African / African-American | 0.00134% | 74,900 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- SPTLC1
- Protein
- p.Ser331=
- Coding
- c.993C>T
- MANE Select
- NM_006415
- dbSNP
- rs141150508
- Type
- single nucleotide variant
- Location
- chr9:92047260 (GRCh38)
- Gene constraint
- LOEUF 1.068 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 94.04 · 17 PDB
- Residue 331
- a UniProt-annotated variant site (in hsan1a; severe form with early onset; reduced canonical activity towards serine and increased production of deoxysphingolipids; no effect on subcellular location at the endoplasmic reticulum); a UniProt-annotated variant site (in als27 and hsan1a; reduced canonical activity towards serine and increased production of deoxysphingolipids); an α-helix
Similar variants
- SPTLC1 p.Ser331Tyr Pathogenic ★★ same residue
- SPTLC1 p.Ser331Phe Pathogenic ★ same residue
- SPTLC1 p.Cys133Trp Pathogenic ★★ same condition
- SPTLC1 p.Cys133Tyr Pathogenic ★★ same condition
- SPTLC1 p.Val144Asp Pathogenic/Likely pathogenic ★★ same condition
- SPTLC1 c.1137-1G>A Uncertain significance ★★ same condition
- SPTLC1 c.1255-3C>T Uncertain significance ★★ same condition
- SPTLC1 c.1329-1G>T Uncertain significance ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/sptlc1-p-ser331 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown